Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Autoimmune haemolytic anaemia

Recruiting

Investigational

Study of rilzabrutinib tablets compared to placebo in adults with warm autoimmune hemolytic anemia

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Rilzabrutinib

Contact Research Centre

Breast cancer

Recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Asthma

Not yet recruiting

Registered drug

Study of Three Doses of Frevecitinib (KN-002) in Adults with Severe Asthma Not Controlled by Medium‑to‑High Dose Inhaled Steroid/LABA Therapy

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Salbutamol Sulfate

Contact Research Centre

Acute haemorrhagic ulcerative colitis

Not recruiting

Registered drugNo placebo

Study Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Chronic kidney disease

Not recruiting

Registered drugNo placebo

Study on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Dapagliflozin

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Investigational

Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Astegolimab

Contact Research Centre

K-ras gene mutation+2

Not recruiting

Registered drugNo placebo

Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on Rifamycin SV for Patients with Mild to Moderate Left-Sided Ulcerative Colitis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Rifamycin Sodium

Contact Research Centre

Type 2 diabetes mellitus

Not recruiting

Registered drugNo placebo

Study Comparing Orforglipron and Dapagliflozin for Adults with Type 2 Diabetes and Poor Blood Sugar Control on Metformin

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Dapagliflozin

Contact Research Centre

Gastric cancer

Not recruiting

Registered drug

Study of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Bemarituzumab

Contact Research Centre

Prostate cancer recurrent

Not recruiting

Registered drugNo placebo

Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Apalutamide

Contact Research Centre

Find therapies in clinical trials near you – page 2

28 trials match your criteria

Autoimmune haemolytic anaemia

Study of rilzabrutinib tablets compared to placebo in adults with warm autoimmune hemolytic anemia

Breast cancer

Study on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Asthma

Study of Three Doses of Frevecitinib (KN-002) in Adults with Severe Asthma Not Controlled by Medium‑to‑High Dose Inhaled Steroid/LABA Therapy

Acute haemorrhagic ulcerative colitis

Study Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis

Chronic kidney disease

Study on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels

Chronic obstructive pulmonary disease

Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

K-ras gene mutation+2

Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

Non-small cell lung cancer metastatic

Study Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Colitis ulcerative

Study on Rifamycin SV for Patients with Mild to Moderate Left-Sided Ulcerative Colitis

Type 2 diabetes mellitus

Study Comparing Orforglipron and Dapagliflozin for Adults with Type 2 Diabetes and Poor Blood Sugar Control on Metformin

Gastric cancer

Study of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression

Prostate cancer recurrent

Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.